Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.
about
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway.The renin/angiotensin system.Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitorThe effect of angiotensin I converting enzyme inhibitor (SQ 20881) on the release of prostaglandins by rabbit kidney, in vivo.Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.Serum angiotensin converting enzyme activity and the capacity to develop hypertention-associated arterial disease. Studies during the induction phase of one-kidney perinephritis hypertension in rabbits.Evidence for dopaminergic vasodilator innervation of the canine paw pad.Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat.Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.Proceedings: The nature of the bradykinin inactivating system in isolated lungs.Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.Captopril treatment of refractory hypertension in children.Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
P2860
Q34235972-2D95FFBA-6FF8-4187-9301-4D07B0B1EDF5Q34449718-D3402A51-718F-4D4B-A09D-DE0EF22CD215Q34516435-F2D9B5E9-E91A-4843-A213-578550EBBE8EQ35176470-2CEA179B-072D-464E-9C4E-ADA6CA102AD0Q35862920-26902EC4-F82F-4954-B275-58FF1C9440A7Q36058884-7AC8C043-789B-4BD7-9AD3-BC59133E5DD0Q36096384-E07ED6B2-936B-4207-8EA4-22198B1EA658Q36756934-E0127B5F-82AF-483F-9B04-3E4804907376Q37013818-7F616D3E-DB98-4738-9C0E-CD8B2AFCC2C1Q37017361-5F88ECCB-1054-43DD-A5A8-A0F807EAC87BQ40011973-C6D862C1-DAC3-4C92-89FD-FCA7939CEB78Q42848366-0E92FF1A-BCDF-4F4E-9CAB-56659B1422E6Q43117523-1428C8A6-DE8A-42A7-A5FA-2013ECFB79D2Q43261523-80DA7155-2AEF-496A-A0EC-3F41012987BF
P2860
Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@en
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@nl
type
label
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@en
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@nl
prefLabel
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@en
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@nl
P2093
P1476
Inhibition of pressor effects ...... dykinin by synthetic peptides.
@en
P2093
P304
P577
1972-05-01T00:00:00Z